OR WAIT 15 SECS
© 2025 MJH Life Sciences™ and Pharmaceutical Commerce - Biopharma Business News, Market Insights. All rights reserved.
AmerisourceBergen exec dives into the shift in Medicare Part D patient requirements.
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Corey Ford, VP of reimbursement & insight policy, AmerisourceBergen, speaks on the Medicare Part D underinsured patient criteria (when it comes to patient assistance programs) and how it has evolved to more of an impact on patients' functionally uninsured criteria at Access PAP 2023.